Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
Rodriguez-Freixinos V, Capdevila J, Pavel ME, Thawer A, Baudin E, O'Toole D, Herrmann K, Welin S, Grozinsky-Glasberg S, de Herder WW, Valle JW, Herman J, Kolarova T, Bouvier C, Falconi M, Ferone D, Singh S (2021)
Publication Type: Journal article, Review article
Publication year: 2021
Journal
Book Volume: 144
Pages Range: 200-214
DOI: 10.1016/j.ejca.2020.11.037
Abstract
Neuroendocrine neoplasms (NENs) are a heterogeneous family of uncommon tumours with challenging diagnosis, clinical management and unique needs that almost always requires a multidisciplinary approach. In the absence of guidance from the scientific literature, along with the rapidly changing data available on the effect of COVID-19, we report how 12 high-volume NEN centres of expertise in 10 countries at different stages of the evolving COVID-19 global pandemic along with members of international neuroendocrine cancer patient societies have suggested to preserve high standards of care for patients with NENs. We review the multidisciplinary management of neuroendocrine neoplasms during the COVID-19 pandemic, and we suggest potential strategies to reduce risk and aid multidisciplinary treatment decision-making. By sharing our joint experiences, we aim to generate recommendations for proceeding to other institutions facing the same challenges.
Authors with CRIS profile
Involved external institutions
Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron
Spain (ES)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
Hadassah Medical Center / מרכז רפואי הדסה
Israel (IL)
International Neuroendocrine Cancer Alliance
United States (USA) (US)
Universitätsklinikum Essen
Germany (DE)
Institut Gustave-Roussy
France (FR)
University of Genova / Università degli Studi di Genova
Italy (IT)
St Vincent's University Hospital
Ireland (IE)
University of Manchester
United Kingdom (GB)
Erasmus University Medical Center (MC)
Netherlands (NL)
Canadian Neuroendocrine Tumour Society
Canada (CA)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
Spain (ES)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
Hadassah Medical Center / מרכז רפואי הדסה
Israel (IL)
International Neuroendocrine Cancer Alliance
United States (USA) (US)
Universitätsklinikum Essen
Germany (DE)
Institut Gustave-Roussy
France (FR)
University of Genova / Università degli Studi di Genova
Italy (IT)
St Vincent's University Hospital
Ireland (IE)
University of Manchester
United Kingdom (GB)
Erasmus University Medical Center (MC)
Netherlands (NL)
Canadian Neuroendocrine Tumour Society
Canada (CA)
Uppsala University Hospital / Akademiska sjukhuset
Sweden (SE)
How to cite
APA:
Rodriguez-Freixinos, V., Capdevila, J., Pavel, M.E., Thawer, A., Baudin, E., O'Toole, D.,... Singh, S. (2021). Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era. European Journal of Cancer, 144, 200-214. https://doi.org/10.1016/j.ejca.2020.11.037
MLA:
Rodriguez-Freixinos, Víctor, et al. "Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era." European Journal of Cancer 144 (2021): 200-214.
BibTeX: Download